Thyroid-stimulating hormone
Biomarker3 papers4 findings
- Humans3
Effects
2Mild cognitive impairment
mediatesin humans1OR 1.012
1 study
Mild cognitive impairment
mediatesin humans1OR 1.012
Thyroid-stimulating hormone mediates mild cognitive impairment in humans (10.23% (ACME OR = 1.012, 95% CI: 1.002-1.022)).
Humansmediating association of 24 h-UIE with MCI
Biofluid iodine concentrations are associated with mild cognitive impairment: The potential mediating role of thyroid hormones · Clinica chimica acta; international journal of clinical chemistry · 21 Sep 2026
Annual decline in eGFR
upin humans1
1 study
Annual decline in eGFR
upin humans1
Thyroid-stimulating hormone increases annual decline in eGFR in humans (0.353 (0.108, 0.598) ml/min/1.73 m2 per 1 log-odds higher exposure).
Humansin CKD population
Disease progression Mendelian randomization of risk factors for kidney function decline in chronic kidney disease and the general population · medRxiv · 8 Sep 2026 · Preprint
Associations
2Cognitive function
downin humans1
1 study
Cognitive function
downin humans1
Thyroid-stimulating hormone is associated with cognitive function in humans.
Humanscross-sectional population study
Biofluid iodine concentrations are associated with mild cognitive impairment: The potential mediating role of thyroid hormones · Clinica chimica acta; international journal of clinical chemistry · 21 Sep 2026
Type 2 diabetes
upin humans1OR 2.82
1 study
Type 2 diabetes
upin humans1OR 2.82
Thyroid-stimulating hormone raises the risk of type 2 diabetes in humans (OR 2.82, 95% CI 1.26-6.32).
Humanshigh TSH levelsn = 4,910
Age- and sex-specific associations between thyroid function and diabetes in Korean adults: A nationwide cross-sectional study · Medicine · 18 Sep 2026